Connect with us

Technology

ARUP Laboratories Adds Cyclospora Data to Infectious Disease Dashboard Amid National Outbreak

Published

on

SALT LAKE CITY, Aug. 3, 2026 /PRNewswire/ — As cyclosporiasis cases continue to rise across the United States, ARUP Laboratories has added Cyclospora test positivity data to its National Infectious Disease Test Positivity Trends Dashboard. This addition helps clinicians, laboratories, and public health professionals monitor the cyclosporiasis outbreak and other emerging infectious disease trends nationwide.

“We designed the dashboard to evolve as new public health needs emerge,” said Ben Bradley, MD, PhD, ARUP head of clinical operations for Infectious Disease and medical director of the Institute for Research and Innovation in Infectious Disease Genomic Technologies, High Consequence Pathogen Response, Virology, and Molecular Infectious Diseases. “The scale and rapid growth of this cyclosporiasis outbreak created strong interest from our clients, and adding Cyclospora data allows us to provide near-real-time visibility into disease activity that complements traditional public health reporting.”

The dashboard expansion comes as public health officials report rising cyclosporiasis activity. As of July 28, 2026, the Centers for Disease Control and Prevention (CDC) had received reports of 6,707  laboratory-confirmed cases across 45 states and was aware of more than 11,500 additional cases undergoing investigation and analysis.  

The National Infectious Disease Test Positivity Trends Dashboard launched in May 2026 as the first tool developed by a U.S. reference laboratory to publicly track laboratory test positivity trends for multiple pathogens. The dashboard features pathogen-specific pages, weekly updates, maps, and charts based on ARUP testing data, and key information highlights designed to help laboratories and clinicians monitor disease activity.

ARUP designed the dashboard with strict privacy safeguards. All information displayed is fully deidentified, and interactivity is intentionally limited to protect patient and client confidentiality.

Access the National Infectious Disease Test Positivity Trends Dashboard.

Read how ARUP’s artificial intelligence-enhanced testing aids in diagnosis.

About ARUP Laboratories

Founded in 1984, ARUP Laboratories is a leading national reference laboratory and a nonprofit enterprise of the Spencer Fox Eccles School of Medicine at the University of Utah and its Department of Pathology. ARUP offers more than 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™. ARUP is ISO 15189 and CAP accredited. For more information, visit www.aruplab.com.

Media Contact

Bonnie Stray
801-583-2787 ext. 2823
media@aruplab.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/arup-laboratories-adds-cyclospora-data-to-infectious-disease-dashboard-amid-national-outbreak-302841138.html

SOURCE ARUP Laboratories

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

PNC Celebrates 50th New Branch Opening Since Launch of Coast-to-Coast Build-Out of More Than 300 Branches

Published

on

By

PNC remains on track to open more than 55 new branches this year

PITTSBURGH, Aug. 3, 2026 /PRNewswire/ — PNC Bank today announced the opening of its 50th new location, an important milestone in the company’s coast-to-coast build-out of more than 300 branches across key U.S. markets. This milestone reflects the strong momentum behind the national bank’s multi-year strategy to invest $2 billion in its branch network, including building locations in 19 markets as well as renovating its existing network across the U.S. PNC remains on track to open 55 new branches in 2026, the largest single-year branch expansion effort in its history.

The Hialeah branch in Hialeah, Florida, which opened Aug. 3, 2026, marks PNC’s 50th new branch opening and represents consistent progress against the bank’s long-term expansion commitments. The recently opened branches span strategic growth markets across the country, including Dallas, Miami, Houston and Denver.

“Our branch network is the heartbeat of our retail business, offering hospitable and relationship-based advice and assistance to the millions of customers who visit us each month,” said Alex Overstrom, head of Retail Banking at PNC. “Reaching our 50th branch opening is an important milestone in what is ultimately a journey to create a ubiquitous network across the United States.”

PNC’s expansion strategy began with a nearly $1 billion commitment announced in February 2024, which included plans to open more than 100 new branches and renovate more than 1,200 existing locations nationwide through 2028. Building on that foundation, PNC expanded the initiative in November 2024 with an additional $500 million investment, increasing its planned branch openings to more than 200 across 12 cities. Most recently, in November 2025, PNC increased its goal to add a total of 300 new branches by 2030, raising its total branch investment to approximately $2 billion. The announcement also expanded the company’s market footprint and reaffirmed its commitment to fully renovate its entire branch network.

PNC recognizes that physical branches continue to play an essential role in fostering trusted relationships, offering personalized financial guidance and supporting complex financial needs. Through its growing network of new and modernized locations, PNC is giving customers greater choice in how they bank, whether online, through the new mobile app or in person, while ensuring that customers have seamless access to the expertise, products and resources they need to achieve their financial goals.

PNC Bank, National Association, is a member of The PNC Financial Services Group, Inc. (NYSE: PNC). PNC is one of the largest diversified financial services institutions in the United States, organized around its customers and communities for strong relationships and local delivery of retail and business banking including a full range of lending products; specialized services for corporations and government entities, including corporate banking, real estate finance and asset-based lending; wealth management and asset management. For information about PNC, visit www.pnc.com.

CONTACT:
Darby Rowe
(717) 824-6314
darby.rowe@pnc.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/pnc-celebrates-50th-new-branch-opening-since-launch-of-coast-to-coast-build-out-of-more-than-300-branches-302841406.html

SOURCE PNC Bank

Continue Reading

Technology

Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing

Published

on

By

PUNE, India, Aug. 3, 2026 /PRNewswire/ — Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), today announced the launch of NeX™, a transformative end-to-end partnership model that enables governments, institutions, and biopharma organizations to establish world-class biomanufacturing capabilities wherever they need them.

Built on the company’s proven EnzeneX® fully‑connected continuous manufacturing™ (FCCM™) platform, NeX delivers a turnkey, scalable, and sustainable way to make state-of-the-art innovation in biologics manufacturing transportable, close to patients and supply chains, and without the prohibitive capital burden of conventional fed‑batch facilities. By enabling local FCCM‑based manufacturing, governments can significantly expand patient affordability and access to life‑saving biologics.

Enzene’s NeX program includes comprehensive build-out and launch coordination with support for facility design and build-out, technology transfer and IP licensing for the EnzeneX platform, workforce development through the company’s SparX™ structured training curriculum, and ongoing operational support during start-up and commercialization. Where required, participating organizations may also receive access to selected products from Enzene’s biosimilar portfolio for manufacture within their own regions.

“A conventional biologics plant often requires between $300 million and $400 million to build,” commented Himanshu Gadgil, Ph.D., CEO of Enzene. “With our fully-connected continuous manufacturing platform, the same output can be achieved for $60–$80 million. The efficiency comes from a compact, integrated system architecture rather than the scale-intensive layouts of fed-batch facilities, allowing for long-term cost advantage and high product yields for locally manufactured biomedicines.  We are already engaged in discussions with multiple governments and corporations all around the world and are looking forward to helping deliver affordable medicines to patients worldwide.”

Enzene’s NeX program is intended to help regions accelerate the establishment of local biopharma capabilities and risk-mitigated supply chains, develop domestic scientific talent, and reduce long-term manufacturing costs for local patients. The company estimates that facilities built under the program can achieve validation and commercial readiness in under three years.

For more information, visit www.enzene.com/nex.

About Enzene

Enzene is a Continuously Innovative Development and Manufacturing (CIDMO™) partner supporting innovators and biosimilar developers across discovery, development, and commercial supply. Operating from facilities in India and the U.S., Enzene provides integrated biologics development and manufacturing services enabled by its EnzeneX® fully‑connected continuous manufacturing™ (FCCM™) platform, which delivers the world’s leading yields and cost efficiency, and is validated for commercial biologics production.

To expand regional biologics capability, Enzene also offers NeX™, an end‑to‑end partnership program that supports governments, institutions, and biopharma organizations in establishing local biomanufacturing, leveraging all the productivity, operating cost and capital advantages of continuous processing. NeX provides comprehensive facility design guidance, technology and IP transfer, workforce development through its SparX™ training program, operational oversight, and territory‑specific pipeline support.

For more information, visit www.enzene.com.

Media Contact:
Miles Fisher-Pollard
Orientation Marketing
milesfp@orientation.agency

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/enzene-launches-nex-a-comprehensive-suite-of-solutions-to-enable-cost-efficient-high-yielding-local-biomanufacturing-302841414.html

Continue Reading

Technology

American Council of the Blind’s 2026 Conference and Convention Showcases Innovation, Advocacy, and Community

Published

on

By

ALEXANDRIA, Va., Aug. 3, 2026 /PRNewswire/ — The American Council of the Blind (ACB) concluded its 2026 Conference and Convention, bringing together nearly 1,200 virtual and in-person attendees from across the country. Held during ACB’s 65th anniversary year, the convention celebrated ACB’s legacy of advocacy and its continued commitment to advancing accessibility, innovation, and opportunity for people who are blind or have low vision.

Throughout the week, attendees participated in educational sessions on artificial intelligence, advocacy, accessible technology, leadership, employment, and more. The convention also featured ACB affiliate meetings, networking events, and tours of local attractions. ACB’s Exhibit Hall showcased the latest advancements in assistive technology and other innovative products and services.

Advocacy remained a central focus, with sessions highlighting ACB’s legislative priorities, including improving digital accessibility, expanding accessible transportation and healthcare, and advancing equal opportunity for people who are blind or have low vision.

The convention also celebrated the strength of community through youth and scholarship programs, leadership development, and opportunities for attendees to connect, learn, and build lasting relationships.

ACB’s annual banquet featured keynote speaker Precious Perez, a blind musician and advocate, who shared her personal journey, discussed her advocacy work, and performed some of her original music.

“Our annual convention demonstrates what’s possible when our community comes together to share ideas, advocate for change, and embrace innovation,” said ACB Executive Director Scott Thornhill. “The connections made, knowledge shared, and partnerships formed throughout the week will continue to advance opportunities for people who are blind or have low vision.”

ACB extends its sincere appreciation to the volunteers, presenters, exhibitors, affiliates, sponsors, and attendees whose contributions made this year’s convention a success. ACB also offers a special thanks to the convention Diamond Sponsors, Microsoft, Vanda Pharmaceuticals, and Waymo, for their generous support and commitment to advancing accessibility and inclusion.

The 2027 ACB Conference and Convention will be held July 23-30 in Jacksonville, Florida.

About the American Council of the Blind

The American Council of the Blind (ACB) is a national member-driven organization representing Americans who are blind and have low vision. Founded in 1961, ACB works to increase independence, security, equality of opportunity, and quality of life through advocacy, education, community engagement, and information. Learn more at https://www.acb.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/american-council-of-the-blinds-2026-conference-and-convention-showcases-innovation-advocacy-and-community-302841416.html

SOURCE American Council of the Blind

Continue Reading

Trending